CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test
Introduction
The CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test is a revolutionary diagnostic tool designed to identify genetic predispositions to cerebral amyloid angiopathy (CAA), a condition that affects the blood vessels in the brain. This test employs Next-Generation Sequencing (NGS) technology to analyze the CST3 gene, providing critical insights into neurological disorders.
What the Test Measures
This genetic test measures variations in the CST3 gene that may contribute to the development of CAA. By detecting these genetic markers, healthcare providers can better understand an individual’s risk for developing this condition.
Who Should Consider This Test?
Individuals who may benefit from the CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test include:
- Those with a family history of cerebral amyloid angiopathy or related neurological disorders.
- Patients exhibiting symptoms of cognitive decline or unexplained neurological issues.
- Individuals seeking genetic counseling for potential hereditary conditions.
Benefits of Taking the Test
Taking the CST3 Gene test offers numerous benefits, including:
- Early identification of genetic factors contributing to cerebral amyloid angiopathy.
- Informed decision-making regarding health management and treatment options.
- Access to genetic counseling and support for affected families.
Understanding Your Results
Results from the CST3 Gene test will provide insights into your genetic predisposition to CAA. Your healthcare provider will guide you in interpreting these results and discussing potential next steps based on your individual risk profile.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to the test, a clinical history of the patient and a genetic counseling session to draw a pedigree chart of affected family members is recommended.
Book Your Test Today!
We have branches across all major cities in Kenya and offer a convenient home sample collection service. To book the CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test, please call or WhatsApp us at +254713408028.
